| Nasdaq: POZN
POZEN, Inc. manufactures and markets pharmaceutical products. It is pharmaceutical company that specializes in developing novel therapeutics for unmet medical needs and licensing those products to other pharmaceutical companies for commercialization. The company's Pipeline products are PA Product Portfolio, which is focused on integrated aspirin therapies that enable the full power of aspirin by reducing its potential gastrointestinal damage. PA Product Portfolio consists of PA8140 and PA32540. Its licensed products include Treximet, MT 400 and VIMOVO. POZEN was founded by John R. Plachetka on September 25, 1996 and is headquartered in Chapel Hill, NC.